Researchers report that adding a small molecule to a chimeric antigen receptor-T (CAR-T) cell therapy can help immune system T cells to effectively attack solid tumors, such as breast cancers. The boost helps recruit more immune cells into battle at the tumor site, according to the new study. https://www.sciencedaily.com/releases/2020/12/201231100705.htm
|
|
Study points the way to boost immunotherapy against breast cancer, other solid tumors